Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The decision to stop or include additional volunteers was be based on the incretin effect (primary outcome) and the study plan and full adaptive design are listed on the clinicaltrials.gov registry (NCT02723110)
The information and opinions contained in this material are derived from sources deemed to be reliable but should not be assumed to be accurate or complete
Patients primarily taking GLP-1s for Type 2 diabetes still discontinued them at a rate of 46.5 percent
For Mounjaro (tirzepatide), a different medication in the same general class, up to 5% of participants reported hair shedding
US$ 21.07
US$ 20.46
US$ 22.84
US$ 20.80
US$ 26.79
US$ 21.41
